Course of Disordered Eating Behavior in Young People With Early-Onset Type I Diabetes: Prevalence, Symptoms, and Transition Probabilities.


Journal

The Journal of adolescent health : official publication of the Society for Adolescent Medicine
ISSN: 1879-1972
Titre abrégé: J Adolesc Health
Pays: United States
ID NLM: 9102136

Informations de publication

Date de publication:
11 2019
Historique:
received: 13 02 2019
revised: 08 05 2019
accepted: 21 05 2019
pubmed: 3 9 2019
medline: 10 10 2020
entrez: 3 9 2019
Statut: ppublish

Résumé

The aims of this study were to analyze the prevalence and course of disordered eating behavior (DEB) in adolescents with intensively treated type I diabetes, describe differences in age-specific DEB symptoms, and identify predictors of current DEB. Data were taken from 332/218 11- to 27-year-old participants (55.7% girls/women, mean age [SD] 17.8 [3.4] years, mean diabetes duration 14.9 [3.0] years) of two/three surveys of a Germany-wide longitudinal study on early-onset and long duration diabetes, respectively. A diabetes-adapted version of the SCOFF questionnaire was used to assess DEB. Both screening-based overall and age- and sex-specific prevalence of DEB and its symptoms were determined. To estimate transition probabilities between DEB states, first-order Markov transition models were implemented adjusting for previous sociodemographic, socioeconomic, and diabetes-specific covariates. The overall screening-based DEB prevalence among all 1,318 observations was 10.8% (95% confidence interval [CI]: 9.2%, 12.6%) with age-specific differences in symptom prevalence. Transition probabilities for developing/persistent DEB were twofold higher among female than male participants (risk ratio [RR] 2.3 [1.4, 3.9]/2.1 [1.3, 3.4]). In multiple adjusted regression, previous DEB (odds ratio [OR] 2.8 [95% CI 1.4, 5.6]), follow-up time (OR Our results contribute to better understanding the course of DEB in patients with early-onset diabetes and emphasize the relevance of regular DEB screenings including the age group of young adults.

Identifiants

pubmed: 31474433
pii: S1054-139X(19)30306-4
doi: 10.1016/j.jadohealth.2019.05.016
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

681-689

Informations de copyright

Copyright © 2019. Published by Elsevier Inc.

Auteurs

Christina Baechle (C)

German Diabetes Center, Institute for Biometrics and Epidemiology, Düsseldorf, Germany; German Center for Diabetes Research, München-Neuherberg, Germany. Electronic address: christina.baechle@ddz.de.

Annika Hoyer (A)

German Diabetes Center, Institute for Biometrics and Epidemiology, Düsseldorf, Germany; German Center for Diabetes Research, München-Neuherberg, Germany.

Anna Stahl-Pehe (A)

German Diabetes Center, Institute for Biometrics and Epidemiology, Düsseldorf, Germany; German Center for Diabetes Research, München-Neuherberg, Germany.

Katty Castillo (K)

German Diabetes Center, Institute for Biometrics and Epidemiology, Düsseldorf, Germany; German Center for Diabetes Research, München-Neuherberg, Germany.

Thaddaeus Toennies (T)

German Diabetes Center, Institute for Biometrics and Epidemiology, Düsseldorf, Germany; German Center for Diabetes Research, München-Neuherberg, Germany.

Lena M E Lindner (LME)

German Diabetes Center, Institute for Biometrics and Epidemiology, Düsseldorf, Germany; German Center for Diabetes Research, München-Neuherberg, Germany.

Christina Reinauer (C)

University Children's Hospital, Department of General Pediatrics, Neonatology, and Pediatric Cardiology, Medical Faculty at Heinrich Heine University, Düsseldorf, Germany.

Reinhard W Holl (RW)

German Center for Diabetes Research, München-Neuherberg, Germany; Institute of Epidemiology and Medical Biometry, University of Ulm, Ulm, Germany.

Oliver Kuss (O)

German Diabetes Center, Institute for Biometrics and Epidemiology, Düsseldorf, Germany; German Center for Diabetes Research, München-Neuherberg, Germany; Institute of Medical Statistics, Medical Faculty at Heinrich Heine University, Düsseldorf, Germany.

Joachim Rosenbauer (J)

German Diabetes Center, Institute for Biometrics and Epidemiology, Düsseldorf, Germany; German Center for Diabetes Research, München-Neuherberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH